These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 24625530

  • 21. Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis.
    Mugwanya KK, Wyatt C, Celum C, Donnell D, Kiarie J, Ronald A, Baeten JM, Partners PrEP Study Team.
    J Acquir Immune Defic Syndr; 2016 Apr 01; 71(4):374-80. PubMed ID: 26914909
    [Abstract] [Full Text] [Related]

  • 22. Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial.
    Bernardino JI, Mocroft A, Mallon PW, Wallet C, Gerstoft J, Russell C, Reiss P, Katlama C, De Wit S, Richert L, Babiker A, Buño A, Castagna A, Girard PM, Chene G, Raffi F, Arribas JR, NEAT001/ANRS143 Study Group.
    Lancet HIV; 2015 Nov 01; 2(11):e464-73. PubMed ID: 26520926
    [Abstract] [Full Text] [Related]

  • 23. Differential skeletal impact of tenofovir disoproxil fumarate in young versus old HIV-infected adults.
    Grant PM, Kitch D, McComsey GA, Tierney C, Ha B, Brown TT.
    HIV Clin Trials; 2015 Nov 01; 16(2):66-71. PubMed ID: 25872972
    [Abstract] [Full Text] [Related]

  • 24. Bone Density, Microarchitecture, and Tissue Quality After Long-Term Treatment With Tenofovir/Emtricitabine or Abacavir/Lamivudine.
    Güerri-Fernández R, Molina-Morant D, Villar-García J, Herrera S, González-Mena A, Guelar A, Trenchs-Rodríguez M, Díez-Pérez A, Knobel H.
    J Acquir Immune Defic Syndr; 2017 Jul 01; 75(3):322-327. PubMed ID: 28418990
    [Abstract] [Full Text] [Related]

  • 25. Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial.
    Mugo NR, Hong T, Celum C, Donnell D, Bukusi EA, John-Stewart G, Wangisi J, Were E, Heffron R, Matthews LT, Morrison S, Ngure K, Baeten JM, Partners PrEP Study Team.
    JAMA; 2017 Jul 01; 312(4):362-71. PubMed ID: 25038355
    [Abstract] [Full Text] [Related]

  • 26. Emtricitabine/tenofovir disoproxil fumarate: a review of its use in HIV-1 pre-exposure prophylaxis.
    Plosker GL.
    Drugs; 2013 Mar 01; 73(3):279-91. PubMed ID: 23444256
    [Abstract] [Full Text] [Related]

  • 27. Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trial.
    Stranix-Chibanda L, Tierney C, Sebikari D, Aizire J, Dadabhai S, Zanga A, Mukwasi-Kahari C, Vhembo T, Violari A, Theron G, Moodley D, George K, Fan B, Sommer MJ, Browning R, Mofenson LM, Shepherd J, Nelson B, Fowler MG, Siberry GK, PROMISE P1084s study team.
    PLoS One; 2021 Mar 01; 16(2):e0246272. PubMed ID: 33544759
    [Abstract] [Full Text] [Related]

  • 28. Should we fear resistance from tenofovir/emtricitabine preexposure prophylaxis?
    Parikh UM, Mellors JW.
    Curr Opin HIV AIDS; 2016 Jan 01; 11(1):49-55. PubMed ID: 26633640
    [Abstract] [Full Text] [Related]

  • 29. Acute Trigeminal Neuralgia Associated with Initiation of Emtricitabine/Tenofovir for HIV Pre-Exposure Prophylaxis.
    Van Slyke L, Scott M.
    J Int Assoc Provid AIDS Care; 2018 Jan 01; 17():2325958218760846. PubMed ID: 29534653
    [Abstract] [Full Text] [Related]

  • 30. Liver and renal safety of tenofovir disoproxil fumarate in combination with emtricitabine among African women in a pre-exposure prophylaxis trial.
    Mandala J, Nanda K, Wang M, De Baetselier I, Deese J, Lombaard J, Owino F, Malahleha M, Manongi R, Taylor D, Van Damme L.
    BMC Pharmacol Toxicol; 2014 Dec 24; 15():77. PubMed ID: 25539648
    [Abstract] [Full Text] [Related]

  • 31. Kidney function and daily emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis against HIV: results from the real-life multicentric demonstrative project PrEP Brazil.
    Petruccelli KCS, Baía-da-Silva DC, Val F, Valões MS, Cubas-Vega N, Silva-Neto AV, Sampaio V, Alencar A, Pecoits-Filho R, Moreira RC, Cardoso SW, Moreira RI, Leite IC, Madruga JV, Kallas EG, Alencastro PR, Hoagland B, Grinsztejn B, Santos VGV, Lacerda MVG.
    AIDS Res Ther; 2022 Feb 24; 19(1):12. PubMed ID: 35209929
    [Abstract] [Full Text] [Related]

  • 32. HLA alleles association with changes in bone mineral density in HIV-1-infected adults changing treatment to tenofovir-emtricitabine or abacavir-lamivudine.
    Haskelberg H, Cordery DV, Amin J, Kelleher AD, Cooper DA, Emery S, STEAL Study Group.
    PLoS One; 2014 Feb 24; 9(3):e93333. PubMed ID: 24681993
    [Abstract] [Full Text] [Related]

  • 33. Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals.
    Okwundu CI, Uthman OA, Okoromah CA.
    Cochrane Database Syst Rev; 2012 Jul 11; 2012(7):CD007189. PubMed ID: 22786505
    [Abstract] [Full Text] [Related]

  • 34. HIV preexposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine and changes in kidney function and tubular health.
    Ascher SB, Scherzer R, Estrella MM, Shigenaga J, Spaulding KA, Glidden DV, Mehrotra ML, Defechereux P, Gandhi M, Grant RM, Shlipak MG, Jotwani V.
    AIDS; 2020 Apr 01; 34(5):699-706. PubMed ID: 31794523
    [Abstract] [Full Text] [Related]

  • 35. InterPrEP: internet-based pre-exposure prophylaxis with generic tenofovir disoproxil fumarate/emtrictabine in London - analysis of pharmacokinetics, safety and outcomes.
    Wang X, Nwokolo N, Korologou-Linden R, Hill A, Whitlock G, Day-Weber I, McClure MO, Boffito M.
    HIV Med; 2018 Jan 01; 19(1):1-6. PubMed ID: 28657199
    [Abstract] [Full Text] [Related]

  • 36. Short Communication: Association of Vitamin D Insufficiency and Protective Tenofovir Diphosphate Concentrations with Bone Toxicity in Adolescent Boys and Young Men Using Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Pre-Exposure Prophylaxis.
    Havens PL, Tamhane A, Stephensen CB, Schuster GU, Gordon CM, Liu N, Wilson CM, Hosek SG, Anderson PL, Kapogiannis BG, Mulligan K.
    AIDS Res Hum Retroviruses; 2019 Feb 01; 35(2):123-128. PubMed ID: 30280906
    [Abstract] [Full Text] [Related]

  • 37. Bone mineral density changes among people living with HIV who have started with TDF-containing regimen: A five-year prospective study.
    Han WM, Wattanachanya L, Apornpong T, Jantrapakde J, Avihingsanon A, Kerr SJ, Teeratakulpisarn N, Jadwattanakul T, Chaiwatanarat T, Buranasupkajorn P, Ramautarsing R, Phanuphak N, Sunthornyothin S, Ruxrungtham K, Phanuphak P, TNT 003.1 study team.
    PLoS One; 2020 Feb 01; 15(3):e0230368. PubMed ID: 32210458
    [Abstract] [Full Text] [Related]

  • 38. Pre-exposure prophylaxis does not affect the fertility of HIV-1-uninfected men.
    Were EO, Heffron R, Mugo NR, Celum C, Mujugira A, Bukusi EA, Baeten JM, Partners PrEP Study Team.
    AIDS; 2014 Aug 24; 28(13):1977-82. PubMed ID: 25259704
    [Abstract] [Full Text] [Related]

  • 39. Markers of Maternal Bone and Renal Toxicity Through 50 Weeks Postpartum: IMPAACT 2010 (VESTED) Trial.
    Masheto G, Brummel SS, Ziemba L, Shepherd J, Mbengeranwa T, Igawa L, Coletti A, Mukura D, Rossouw L, Theron G, Krotje C, Jean-Philippe P, Chakhtoura N, Cassim H, Mathiba SR, Maena J, Murtaugh W, Fairlie L, Currier J, Hoffman R, Chinula L, Sax PE, Stranix-Chibanda L, Lockman S, IMPAACT 2010/VESTED Study Team and Investigators.
    J Acquir Immune Defic Syndr; 2024 Oct 01; 97(2):172-179. PubMed ID: 39250651
    [Abstract] [Full Text] [Related]

  • 40. Daily oral tenofovir and emtricitabine-tenofovir preexposure prophylaxis reduces herpes simplex virus type 2 acquisition among heterosexual HIV-1-uninfected men and women: a subgroup analysis of a randomized trial.
    Celum C, Morrow RA, Donnell D, Hong T, Hendrix CW, Thomas KK, Fife KH, Nakku-Joloba E, Mujugira A, Baeten JM, Partners PrEP Study Team.
    Ann Intern Med; 2014 Jul 01; 161(1):11-9. PubMed ID: 24979446
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.